Cigna Corporation
CI
Rangering i aksjer
#306
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut,... Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
Aksjekurs
$299.33
Sist synkronisert: 2026-10-19
Markedsverdi
$79.10B
Endring (1 dag)
-1.01%
Endring (1 år)
-2.45%
Land
US
Handel Cigna Corporation (CI)
Kategori
Healthcare
P/E-forhold for Cigna Corporation (CI)
P/E-forhold per October 2026 TTM: 11.94
Ifølge Cigna Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 11.94. Ved slutten av 2024 hadde selskapet en P/E på 22.54.
P/E-forholdshistorikk for Cigna Corporation fra 2000 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 11.94 | -2.84% |
| 2025 | 12.29 | -45.48% |
| 2024 | 22.54 | 30.92% |
| 2023 | 17.22 | 11.26% |
| 2022 | 15.47 | 7.07% |
| 2021 | 14.45 | 60.87% |
| 2020 | 8.98 | -40.35% |
| 2019 | 15.06 | -15.22% |
| 2018 | 17.76 | -19.59% |
| 2017 | 22.09 | 21.08% |
| 2016 | 18.24 | 1.93% |
| 2015 | 17.90 | 38.55% |
| 2014 | 12.92 | -21.95% |
| 2013 | 16.55 | 76.44% |
| 2012 | 9.38 | 3.98% |
| 2011 | 9.02 | 15.37% |
| 2010 | 7.82 | 5.35% |
| 2009 | 7.42 | -53.61% |
| 2008 | 16.00 | 17.27% |
| 2007 | 13.65 | 8.59% |
| 2006 | 12.57 | 43.58% |
| 2005 | 8.75 | 13.10% |
| 2004 | 7.74 | -39.17% |
| 2003 | 12.72 | -198.06% |
| 2002 | -12.97 | -187.25% |
| 2001 | 14.87 | -31.90% |
| 2000 | 21.84 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 22.58 | 89.09% |
US
|
|
| 23.60 | 97.64% |
US
|
|
| 19.03 | 59.33% |
US
|
|
| 40.15 | 236.22% |
US
|
|
| - | - |
US
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.